HYPERION DEFI, INC. Operating Cash Flow
HYPERION DEFI, INC. (HYPD) reported Operating Cash Flow of -$7.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- HYPERION DEFI, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.90M.
- HYPERION DEFI, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.20M.
- HYPERION DEFI, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.06M.
- HYPERION DEFI, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$2.82M.
- HYPERION DEFI, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$14.77M.
- HYPERION DEFI, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$30.12M.
- HYPERION DEFI, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$23.84M.
- HYPERION DEFI, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$25.11M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$7.09M 10-Q · filed 2026-08-13 | -$11.15M derived: sum of 3 quarters · filed 2026-08-13 | -$13.97M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$4.20M 10-Q · filed 2026-05-15 | -$8.25M derived: sum of 2 quarters · filed 2026-05-15 | -$11.08M derived: sum of 3 quarters · filed 2026-05-15 | -$14.52M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$6.88M derived: sum of 2 quarters · filed 2026-03-30 | -$10.33M derived: sum of 3 quarters · filed 2026-08-13 | -$14.77M 10-K · filed 2026-03-30 | |
| 2025-09-30 | -$2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$6.27M derived: sum of 2 quarters · filed 2026-08-13 | -$10.71M 10-Q · filed 2025-11-14 | -$16.82M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$3.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$7.89M 10-Q · filed 2026-08-13 | -$14.00M derived: sum of 3 quarters · filed 2026-08-13 | -$19.94M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$4.44M 10-Q · filed 2026-05-15 | -$10.55M derived: sum of 2 quarters · filed 2026-05-15 | -$16.50M derived: sum of 3 quarters · filed 2026-05-15 | -$24.67M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$6.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$12.05M derived: sum of 2 quarters · filed 2026-03-30 | -$20.23M derived: sum of 3 quarters · filed 2026-03-30 | -$30.12M 10-K · filed 2026-03-30 | |
| 2024-09-30 | -$5.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$14.12M derived: sum of 2 quarters · filed 2025-11-14 | -$24.01M 10-Q · filed 2025-11-14 | -$30.33M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$8.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$18.07M 10-Q · filed 2025-08-13 | -$24.39M derived: sum of 3 quarters · filed 2025-08-13 | -$30.23M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$9.89M 10-Q · filed 2025-05-19 | -$16.21M derived: sum of 2 quarters · filed 2025-05-19 | -$22.05M derived: sum of 3 quarters · filed 2025-05-19 | -$26.77M derived: sum of 4 quarters · filed 2025-05-19 | |
| 2023-12-31 | -$6.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$12.16M derived: sum of 2 quarters · filed 2025-04-15 | -$16.88M derived: sum of 3 quarters · filed 2025-04-15 | -$23.84M 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$5.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$10.56M derived: sum of 2 quarters · filed 2024-11-12 | -$17.51M 10-Q · filed 2024-11-12 | -$22.92M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$4.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$11.67M 10-Q · filed 2024-08-14 | -$17.08M derived: sum of 3 quarters · filed 2024-08-14 | -$23.90M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$6.96M 10-Q · filed 2024-05-15 | -$12.36M derived: sum of 2 quarters · filed 2024-05-15 | -$19.18M derived: sum of 3 quarters · filed 2024-05-15 | -$23.88M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$12.22M derived: sum of 2 quarters · filed 2024-03-18 | -$16.92M derived: sum of 3 quarters · filed 2024-03-18 | -$25.11M 10-K · filed 2024-03-18 | |
| 2022-09-30 | -$6.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$11.52M derived: sum of 2 quarters · filed 2023-11-13 | -$19.70M 10-Q · filed 2023-11-13 | -$32.38M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$4.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$12.88M 10-Q · filed 2023-08-11 | -$25.56M derived: sum of 3 quarters · filed 2023-08-11 | -$23.85M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | -$8.18M 10-Q · filed 2023-05-12 | -$20.86M derived: sum of 2 quarters · filed 2023-05-12 | -$19.16M derived: sum of 3 quarters · filed 2023-05-12 | -$24.48M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | -$12.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$10.97M derived: sum of 2 quarters · filed 2023-05-12 | -$16.30M derived: sum of 3 quarters · filed 2023-05-12 | -$20.87M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | -$3.63M derived: sum of 2 quarters · filed 2023-05-12 | -$8.20M 10-Q · filed 2023-05-12 | -$15.00M 10-Q · filed 2021-11-12 | -$2.73M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-06-30 | -$5.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$9.90M 10-Q · filed 2022-08-11 | -$4.43M derived: sum of 3 quarters · filed 2022-08-11 | -$6.37M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$4.57M 10-Q · filed 2022-05-13 | $895.25K derived: sum of 2 quarters · filed 2022-05-13 | -$1.04M derived: sum of 3 quarters · filed 2022-05-13 | -$5.04M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $5.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $3.53M derived: sum of 2 quarters · filed 2022-03-30 | -$466.35K derived: sum of 3 quarters · filed 2022-03-30 | -$6.38M 10-K · filed 2022-03-30 | |
| 2020-09-30 | -$1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$5.94M derived: sum of 2 quarters · filed 2021-11-12 | -$11.85M 10-Q · filed 2021-11-12 | -$15.87M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$9.92M 10-Q · filed 2021-08-12 | -$13.94M derived: sum of 3 quarters · filed 2021-08-12 | -$17.80M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$5.92M 10-Q · filed 2021-05-14 | -$9.94M derived: sum of 2 quarters · filed 2021-05-14 | -$13.80M derived: sum of 3 quarters · filed 2021-05-14 | -$18.94M derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | -$4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$7.88M derived: sum of 2 quarters · filed 2021-03-30 | -$13.02M derived: sum of 3 quarters · filed 2021-03-30 | -$18.92M 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$3.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$9.00M derived: sum of 2 quarters · filed 2020-11-12 | -$14.90M 10-Q · filed 2020-11-12 | -$19.00M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | -$5.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$11.04M 10-Q · filed 2020-08-14 | -$15.15M derived: sum of 3 quarters · filed 2020-08-14 | -$18.72M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | -$5.90M 10-Q · filed 2020-05-14 | -$10.00M derived: sum of 2 quarters · filed 2020-05-14 | -$13.58M derived: sum of 3 quarters · filed 2020-05-14 | -$16.62M derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | -$4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$7.68M derived: sum of 2 quarters · filed 2020-03-30 | -$10.72M derived: sum of 3 quarters · filed 2020-03-30 | -$13.11M 10-K · filed 2020-03-30 | |
| 2018-09-30 | -$3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$6.61M derived: sum of 2 quarters · filed 2019-11-13 | -$9.01M 10-Q · filed 2019-11-13 | -$11.00M derived: sum of 4 quarters · filed 2019-11-13 | |
| 2018-06-30 | -$3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$5.43M 10-Q · filed 2019-08-13 | -$7.42M derived: sum of 3 quarters · filed 2019-08-13 | -$8.25M derived: sum of 4 quarters · filed 2019-08-13 | |
| 2018-03-31 | -$2.39M 10-Q · filed 2019-05-14 | -$4.38M derived: sum of 2 quarters · filed 2019-05-14 | -$5.21M derived: sum of 3 quarters · filed 2019-05-14 | -$6.25M derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | -$2.82M derived: sum of 2 quarters · filed 2019-03-27 | -$3.86M derived: sum of 3 quarters · filed 2019-03-27 | -$4.73M 10-K · filed 2019-03-27 | |
| 2017-09-30 | -$824.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$1.87M derived: sum of 2 quarters · filed 2018-11-13 | -$2.74M 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$1.91M 10-Q · filed 2018-08-14 | |||
| 2017-03-31 | -$868.88K 10-Q · filed 2018-05-09 | ||||
| 2016-12-31 | -$3.20M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |